Nanjing, China

Xiao Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiao Wang. Retrieved from https://idiyas.com/inventor/xiao-wang-i1yssxk3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Xiao Wang

Introduction

Xiao Wang is an inventor based in Nanjing, China. He is currently associated with Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Despite having no patents to his name, his contributions to the field of pharmaceuticals are noteworthy.

Latest Patents

As of now, Xiao Wang has not registered any patents. This does not diminish his potential as an inventor, as many innovators contribute to their fields in various ways beyond patenting their ideas.

Career Highlights

Xiao Wang has built a career in the pharmaceutical industry, where he focuses on research and development. His work at Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. has allowed him to collaborate with talented professionals in the field.

Collaborations

Xiao Wang has worked alongside notable colleagues such as Peng Yang and Haiping Hao. Their teamwork fosters a creative environment that encourages innovation and the development of new ideas.

Conclusion

Xiao Wang's journey as an inventor reflects the diverse paths that innovation can take. His work in the pharmaceutical industry, despite the absence of patents, showcases his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…